JOHNSON & JOHNSON is 416.6x more valuable than PRECIGEN, INC. by market capitalization ($573.98 B vs $1.38 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | PGEN | JNJ |
|---|---|---|
| Market cap | $1.38 B | $573.98 B |
| US-listed rank | #2403 | #20 |
| Revenue (latest FY) | $9.68M | $94.19B |
| Net income (latest FY) | -$250.60M | $26.80B |
| Net margin | -2587.8% | 28.5% |
| P/E (trailing FY) | - | 21.4 |
| SEC filings | 1,273 | 984 |
JOHNSON & JOHNSON is 416.6x more valuable than PRECIGEN, INC. by market capitalization ($573.98 B vs $1.38 B).
In their latest fiscal years, PRECIGEN, INC. reported $9.68M in revenue while JOHNSON & JOHNSON reported $94.19B.
Full pages: PRECIGEN, INC. and JOHNSON & JOHNSON, or browse the full rankings.